{"cdcTestId":"2013-0206","testcaseName":"Dose 1 to dose 3 interval 16 weeks-4 days. Series complete. ","vaccineGroup":"HepB","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-04-05T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-07-03T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-26T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-07-03T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-26T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-18T08:01:31.106","generalDescription":"This test case describes when dose #3 of the Hep B vaccine is administered at an interval of 16 weeks - 4 days from dose #1 that the dose is considered to be valid.  The series is complete.","changedInVersion":"1.0","reasonForChange":""}